-
Add 2ml bacteriostatic water to the vial.
- Allow the peptide to dissolve gently. Avoid shaking aggressively.
-
This will provide the following approximate concentrations:5 units (0.05ml) = 0.75mg10 units (0.1ml) = 1.5mg20 units (0.2ml) = 3mg40 units (0.4ml) = 6mg
Retatrutide 30MG Peptide
R1,990.00
NEXT-GENERATION RESEARCH PEPTIDE
- GLP-1 receptors
- GIP receptors
- Glucagon receptors
INCLUDED IN YOUR ORDER
- 1 x 30mg Vial of Retatrutide
- 5 x 1ml Disposable Insulin syringes with needles
- 1 x Bacteriostatic Water Vial
Peptide Labs South Africa supplies high-purity Retatrutide 30mg in lyophilised form for research purposes only.
Suggested Weekly Dosage Schedule/Injection Protocol*
-
Weeks 1–41.5mg once weekly10 units on an insulin syringe
-
Weeks 5–83mg once weekly20 units on an insulin syringe
-
Weeks 9–124.5mg once weekly30 units on an insulin syringe
-
Weeks 13–166mg once weekly40 units on an insulin syringe
- Store in a cool, dry place
- Refrigeration recommended for optimal stability
- After Reconstitution
- Store refrigerated at 2–8°C
- Avoid direct sunlight and heat exposure
- Do not freeze
- Best used within 30–60 days
- a 2–4 week break, or
- a lower-dose maintenance phase before restarting.
- This approach may help support long-term metabolic pathways and reduce adaptation over time.
Discover the benefits of Retatrutide for weight loss in South Africa.
Research suggests that Retatrutide may support:
Retatrutide 30MG Peptide is one of the newest and most powerful multi-agonist peptides currently being studied for its impressive effects on body fat reduction and overall metabolic health.
-
Reduced appetite,
-
Improved satiety,
-
Enhanced metabolic activity,
-
and long-term body composition management.
Due to its potency and long active duration, Retatrutide is commonly utilised in gradual once-weekly administration protocols.
If you want to start on a less potent strength Retatrutide dosage – View our Retatrutide 20MG Peptide
Read more on Retatrutide from the National Library of Medicine here↗
Potential Research Areas
-
Potential Research Areas
-
Weight-management pathway research
-
Appetite regulation research
-
GLP-1 receptor pathway support
-
GIP receptor pathway support
-
Glucagon receptor pathway support
-
Metabolic efficiency research
-
Body composition research
-
Satiety and hunger signalling research
-
Long-term metabolic health studies
Common Notes
Some individuals may experience:
-
nausea,
-
reduced appetite,
-
bloating,
-
reflux,
-
constipation,
-
fatigue,
-
or digestive discomfort,
-
particularly during the early stages of dose escalation.
Protocols commonly recommend:
-
gradual dose progression,
-
adequate hydration,
-
smaller meal sizes,
-
avoiding heavy high-fat meals,
-
and maintaining consistent weekly administration.
-
These effects are commonly reported during adjustment phases and may improve over time.
Disclaimer
-
For research purposes only
-
Not intended to diagnose, treat, cure, or prevent any disease
-
Not medical advice
-
Use sterile procedures when handling peptides




